Exoskeleton Market Segment Analysis By Mobility, Technology, Extremity, End-Use, Region And Forecast Till 2030 : Grand View Research Inc.

San Francisco, 29 March 2022: The Report Exoskeleton Market Size, Share & Trends Analysis Report By Mobility (Mobile, Fixed), By Technology (Powered, Non-powered), By Extremity, By End-use, By Region, And Segment Forecasts, 2022 – 2030

The global exoskeleton market size is expected to reach USD 1.3 billion in terms of revenue and 26,114 units in terms of volume by 2030 and is expected to expand at a CAGR of 18.0% in terms of revenue and 11.0% in terms of volume from 2022 to 2030, according to a new report by Grand View Research, Inc. Rapidly growing global geriatric population, increasing incidences of road accidents, rising prevalence of stroke is boosting the adoption of exoskeleton products and driving the market growth. As per National Safety Council data estimates in March 2021, 42,060 individuals have died in road accidents in 2020 and accounted for an increase of 8% as compared to 2019. Furthermore, the market is expected to witness the emergence of smarter & more competent exoskeletons through the integration of artificial intelligence and machine learning algorithms.

The mobile exoskeleton segment dominated in 2021 and is anticipated to grow lucratively over the forthcoming years owing to the emergence of innovative mobile exoskeletons for the disabled communities and geriatric population. Although, high costs and complications associated with mobile systems are expected to restrain the segment growth. The powered technology segment dominated in 2021 owing to the widespread adoption of powered exoskeletons for rehabilitation aid in patients suffering from spinal cord injuries. Moreover, the benefits provided by these products are restored mobility, improved functioning, and enhanced quality of life. The non-powered technology segment is anticipated to register the fastest growth over the forthcoming years owing to the surge in product launches and growing demand for non-powered exoskeleton products in several industries.

Lower body extremity dominated in 2021 owing to the growing incidence rate of lower body disabilities. On the other hand, upper body extremity is anticipated to register the fastest growth over the forthcoming years owing to the widespread adoption of exoskeleton devices by disabled individuals in managing daily activities. Based on end-use, the healthcare segment dominated in 2021 owing to the growing prevalence of stroke, a significant rise in road accidents, and the growing demand for rehabilitation services. The industry segment is expected to grow significantly over the forecast period owing to the growing adoption rate of exoskeleton products to enhance strength, reduce fatigue and strain amongst workers in several industries. In 2021, North America dominated the market owing to the readiness in adopting advanced novel technologies and the growing prevalence of spinal cord injuries. The Asia Pacific is expected to grow lucratively owing to the advancements in healthcare infrastructure, availability of favorable funding options, and growing patient pool requiring rehabilitation services.

Access Research Report of Exoskeleton Market @ https://www.grandviewresearch.com/industry-analysis/exoskeleton-market

Exoskeleton Market Report Highlights

• The market size is anticipated to be valued at USD 1.3 billion in terms of revenue and 26,114 units in terms of volume by 2030, owing to the growing prevalence of spinal cord injuries and rising demand for exoskeleton products to enhance mobility & boost productivity
• The mobile mobility segment dominated in 2021 owing to multiple benefits associated with these products such as improving strength without restricting movement
• The powered technology segment dominated the market in 2021 owing to the growing number of innovative product launches and an increase in product approvals from regulatory bodies
• The lower body extremity segment dominated the market in 2021 owing to the rising incidence of lower body disabilities
• The healthcare segment dominated the market in 2021 owing to the growing availability of adequate healthcare infrastructure and constant technological advancements
• North America dominated the market in 2021 owing to the growing disabled population, rising prevalence of spinal cord injuries, and presence of key players

List of Key Players of Exoskeleton Market

• Ekso Bionics
• Hocoma
• Lockheed Martin Corporation
• Suit X (U.S. Bionics, Inc.)
• Rex Bionics Plc.
• RB3D
• ReWalk Robotics Ltd
• Cyberdyne, Inc.
• ActiveLink (Panasonic Corporation)

Access Press Release of Exoskeleton Market @ https://www.grandviewresearch.com/press-release/global-exoskeleton-market

Exoskeleton Market Size Is Expected To Reach USD 1.3 Billion By 2030: Grand View Research Inc.

San Francisco, 17 Feb 2022: The Report Exoskeleton Market Size, Share & Trends Analysis Report By Mobility (Mobile, Fixed), By Technology (Powered, Non-powered), By Extremity, By End-use, By Region, And Segment Forecasts, 2022 – 2030

The global exoskeleton market size is expected to reach USD 1.3 billion in terms of revenue and 26,114 units in terms of volume by 2030 and is expected to expand at a CAGR of 18.0% in terms of revenue and 11.0% in terms of volume from 2022 to 2030, according to a new report by Grand View Research, Inc. Rapidly growing global geriatric population, increasing incidences of road accidents, rising prevalence of stroke is boosting the adoption of exoskeleton products and driving the market growth. As per National Safety Council data estimates in March 2021, 42,060 individuals have died in road accidents in 2020 and accounted for an increase of 8% as compared to 2019. Furthermore, the market is expected to witness the emergence of smarter & more competent exoskeletons through the integration of artificial intelligence and machine learning algorithms.

The mobile exoskeleton segment dominated in 2021 and is anticipated to grow lucratively over the forthcoming years owing to the emergence of innovative mobile exoskeletons for the disabled communities and geriatric population. Although, high costs and complications associated with mobile systems are expected to restrain the segment growth. The powered technology segment dominated in 2021 owing to the widespread adoption of powered exoskeletons for rehabilitation aid in patients suffering from spinal cord injuries. Moreover, the benefits provided by these products are restored mobility, improved functioning, and enhanced quality of life. The non-powered technology segment is anticipated to register the fastest growth over the forthcoming years owing to the surge in product launches and growing demand for non-powered exoskeleton products in several industries.

Lower body extremity dominated in 2021 owing to the growing incidence rate of lower body disabilities. On the other hand, upper body extremity is anticipated to register the fastest growth over the forthcoming years owing to the widespread adoption of exoskeleton devices by disabled individuals in managing daily activities. Based on end-use, the healthcare segment dominated in 2021 owing to the growing prevalence of stroke, a significant rise in road accidents, and the growing demand for rehabilitation services. The industry segment is expected to grow significantly over the forecast period owing to the growing adoption rate of exoskeleton products to enhance strength, reduce fatigue and strain amongst workers in several industries. In 2021, North America dominated the market owing to the readiness in adopting advanced novel technologies and the growing prevalence of spinal cord injuries. The Asia Pacific is expected to grow lucratively owing to the advancements in healthcare infrastructure, availability of favorable funding options, and growing patient pool requiring rehabilitation services.

Access Research Report of Exoskeleton Market @ https://www.grandviewresearch.com/industry-analysis/exoskeleton-market

Exoskeleton Market Report Highlights

• The market size is anticipated to be valued at USD 1.3 billion in terms of revenue and 26,114 units in terms of volume by 2030, owing to the growing prevalence of spinal cord injuries and rising demand for exoskeleton products to enhance mobility & boost productivity
• The mobile mobility segment dominated in 2021 owing to multiple benefits associated with these products such as improving strength without restricting movement
• The powered technology segment dominated the market in 2021 owing to the growing number of innovative product launches and an increase in product approvals from regulatory bodies
• The lower body extremity segment dominated the market in 2021 owing to the rising incidence of lower body disabilities
• The healthcare segment dominated the market in 2021 owing to the growing availability of adequate healthcare infrastructure and constant technological advancements
• North America dominated the market in 2021 owing to the growing disabled population, rising prevalence of spinal cord injuries, and presence of key players

List of Key Players of Exoskeleton Market

• Ekso Bionics
• Hocoma
• Lockheed Martin Corporation
• Suit X (U.S. Bionics, Inc.)
• Rex Bionics Plc.
• RB3D
• ReWalk Robotics Ltd
• Cyberdyne, Inc.
• ActiveLink (Panasonic Corporation)

Access Press Release of Exoskeleton Market @ https://www.grandviewresearch.com/press-release/global-exoskeleton-market

Exoskeleton Market Poised To Augment The Industry At $ 3.3 Billion By 2025 : Grand View Research Inc.

San Francisco, 26 July 2019: The Report Exoskeleton Market Size, Share & Trends Analysis Report By Type (Mobile, Stationary), By Drive Type, By End-use (Healthcare, Military, Industrial), And Segment Forecasts, 2018 – 2025

The global exoskeleton market is expected to reach USD 3.3 billion by 2025, according to a new report published by Grand View Research. Key factors driving the market expansion include the increasing number of U.S. FDA products, growing demand for exoskeletons in rehabilitation, assisted walking, military applications, and industrial applications.

The market is evolving rapidly due to the increasing adoption of exoskeleton technology in the developed regions. The growing geriatric population coupled with increasing number of people suffering with paraplegia, tetraplegia, and other spinal cord injuries are major factors boosting the usage rates of exoskeletons.

The exoskeleton market has gained high momentum after the launch of products such as ReWalk bionic suit, Ekso GT exoskeleton. Moreover, with the U.S. FDA approving the Parker Indego, commercialization of exoskeleton devices is expected to increase significantly over the next few years.

In the U.S., the Defense Advanced Research Projects Agency (DARPA), National Aeronautics and Space Administration (NASA), and National Institute of Health (NIH) have significantly contributed toward technology development, research funding, and commercialization of these devices.

• For instance, in 2014, Ekso Bionics received a P20 Exploratory Grant from the NIH to continue the development of an exoskeleton prototype for children.
• In October, 2015, Parker Hannifin Corporation announced that it had agreed to supply Indego exoskeleton for a 4-year multicenter study for the Department of Defense, which was funded by the U.S. Department of Defense and the Congressionally Directed Medical Research Programs.

In the EU, the Robo-Mate project, which comprises of 12 partners from 7 European nations, has received a total funding of Euro 4.5 million by the 7th Framework Program for Research and Technological Development of the European Union. Furthermore, classification of Cyberdyne HAL exoskeleton as medical device in the EU and Japan has reinforced the growth prospects and improved the reimbursement scenario.

Access Research Report of Exoskeleton Market @  www.grandviewresearch.com/industry-analysis/exoskeleton-market

Further Key Findings from the Study Suggest:

• The data published by the International Federation of Robotics suggests that in 2014, nearly 272 exoskeletons were sold commercially, and this number is anticipated to grow rapidly over the next few years.
• In 2015, the healthcare segment accounted for the maximum revenue share of 54.1%. The use of exoskeletons for rehabilitation and assisted living services is a key factor driving the segments growth. However, the industrial segment is expected to emerge as the fastest growing with a high CAGR of 58.8%. Increasing age of workforce coupled with growing healthcare disorders are expected to boost the use of automation and drive the sales of exoskeletons over the forecast period.
• In 2015, North America was a clear leader with a revenue share of 49.8%. The research on exoskeletons was primarily initiated with the USD 50 million funding received from DARPA, and subsequent grants from NIH and NASA have contributed to the development of a strong ecosystem for the proliferation of exoskeleton technology. Moreover, the U.S. Department of Veteran Affairs had issued a national coverage policy for ReWalk robotic exoskeleton systems for eligible veterans with spinal cord injury. This policy is expected to significantly benefit the veterans and propel the usage rates over the forecast period
• Asia Pacific is expected to emerge as the fastest growing region with a CAGR of 57.4% during the forecast period. The growing geriatric population in Japan and China, increase in the spinal cord injuries, and growing industrialization in this region are expected promote the utilization of exoskeletons for healthcare and industrial applications.
• The exoskeleton market is presently dominated by few key participants such as ReWalk, Ekso Bionics, Cyberdyne, and Lockheed Martin. Some of the new players include Rex Bionics, Hocoma, Panasonic- ActiveLink and Parker Hannifin Corporation. Introduction of low cost exoskeletons is expected to increase the competition and is also expected to benefit several patients over the forecast period

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the exoskeleton market by type, technology, end use, and region:

Exoskeleton Market Technology (Type) Outlook (Market revenue in USD Million, 2013 – 2025)

• Mobile Exoskeleton
• Stationary Exoskeleton

Exoskeleton Mobile Technology Market Outlook (Market Revenue in USD Million, 2013 – 2025)

• Active
• Passive

Exoskeleton Stationary Technology Outlook (Market Revenue in USD Million, 2013 – 2025)

• Active
• Passive

Exoskeleton Market Technology (Drive System) Outlook (Market Revenue in USD Million, 2013 – 2025)

• Pneumatic Actuator
• Hydraulic
• Electric Servo
• Electric Actuator
• Fully Mechanical
• Shape Memory Alloy Actuator

Exoskeleton Market End-User Outlook (Market Revenue in USD Million, 2013 – 2025)

• Healthcare
• Military
• Industrial

Exoskeleton Market Regional Outlook (Market Revenue in USD Million, 2013 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Access Press Release of Exoskeleton Market @ www.grandviewresearch.com/press-release/global-exoskeleton-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com